MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MPLT MapLight Therapeutics, Inc.

Post-Mkt 08-21 17:01:53 EDT

11.21

-0.02

-0.18%

盘后11.11

-0.10-0.89%

16:19 EDT

High11.61	Low11.07	Vol435.20K
Open11.35	D1 Closing11.23	Amplitude4.85%
Mkt Cap519.90M	Tradable Cap150.24M	Total Shares46.38M
T/O4.90M	T/O Rate3.25%	Tradable Shares13.40M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":11.21,"timestamp":1787342400000,"preClose":11.23,"halted":0,"volume":435204,"hourTrading":{"tag":"盘后","latestPrice":11.11,"preClose":11.21,"latestTime":"16:19 EDT","volume":6402,"amount":71764.91553,"timestamp":1787343578541,"change":-0.1,"changeRate":-0.008921,"amplitude":0.008921},"delay":0,"changeRate":-0.0017809439002671036,"floatShares":13402700,"shares":46377800,"eps":-5.058,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"08-21 17:01:53 EDT","open":11.35,"high":11.61,"low":11.065,"amount":4896466,"amplitude":0.048531,"askPrice":11.54,"askSize":16,"bidPrice":11,"bidSize":65,"shortable":3,"etf":0,"ttmEps":-5.058,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787356800000},"marketStatusCode":4,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":11.23,"preHourTrading":{"tag":"盘前","latestPrice":11.25,"preClose":11.23,"latestTime":"09:02 EDT","volume":70,"amount":795.914945,"timestamp":1787317349479,"change":0.02,"changeRate":0.001781,"amplitude":0.017809},"postHourTrading":{"tag":"盘后","latestPrice":11.11,"preClose":11.21,"latestTime":"16:19 EDT","volume":6402,"amount":71764.91553,"timestamp":1787343578541,"change":-0.1,"changeRate":-0.008921,"amplitude":0.008921},"volumeRatio":0.708379,"impliedVol":0.882,"impliedVolPercentile":0.1864},"requestUrl":"/m/hq/s/MPLT/wiki","defaultTab":"wiki","newsList":[{"id":"2660490191","title":"Catalyst4 Acquires $50.07 Million of MapLight Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490191","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490191?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:56","pubTimestamp":1787093780,"startTime":"0","endTime":"0","summary":"Catalyst4 acquires $50.07 million of MapLight Therapeutics common sharesCatalyst4 increased its Maplight Therapeutics stake with a purchase of 4.4 million voting common shares at USD 11.38 each.Benefi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbk2NP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Catalyst4 Acquires $50.07 Million of MapLight Therapeutics Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660248003","title":"Morgan Stanley Keeps Their Hold Rating on MapLight Therapeutics, Inc. (MPLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248003","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660248003?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:57","pubTimestamp":1786971453,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on MapLight Therapeutics, Inc., with a price target of $21.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074172","title":"MapLight Therapeutics price target lowered to $21 from $24 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074172?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:18","pubTimestamp":1786886308,"startTime":"0","endTime":"0","summary":"Canaccord analyst Sumant Kulkarni lowered the firm’s price target on MapLight Therapeutics (MPLT) to $21 from $24 and keeps a Buy rating on the sha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-21-from-24-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-21-from-24-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140382","title":"Analysts’ Top NA Picks: Solv Energy (MWH), MapLight Therapeutics, Inc. (MPLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140382?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:40","pubTimestamp":1786718411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Solv Energy (MWH) and MapLight Therapeutics, Inc. (MPLT) wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-solv-energy-mwh-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-solv-energy-mwh-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4141","MWH","NA","BK4129","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616715","title":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616715","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616715?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:27","pubTimestamp":1786652832,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/MPLT","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MapLight Therapeutics Q2 EPS $(1.32) Beats $(1.35) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162232","title":"MapLight Q2 FY26 Net Loss Widens to $60.19 Million; R&D Expenses Rise to $53.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162232","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162232?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:11","pubTimestamp":1786651916,"startTime":"0","endTime":"0","summary":"MapLight Q2 FY26 net loss widens to $60.19 million; R&D expenses rise to $53.44 millionMapLight Therapeutics posted a Q2 net loss of $60.19 million, widening from $29.85 million a year earlier.R&D exp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL64hVdL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999014021.USD","SG9999014039.USD","BK4588","LU2095319765.USD","MPLT","LU2210150020.SGD","IE00BN0W2W23.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4112","BK4139","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162663","title":"Press Release: MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162663","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162663?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"trial of ML-007C-MA in adults with schizophrenia experiencing an acute. exacerbation of psychosis. The trial met its primary endpoint, with the. 210/3 mg twice-daily dose demonstrating a statistically significant and. clinically meaningful reduction in PANSS total score compared with. -- ML-007C-MA also demonstrated improvement on a prespecified. impairment and significant separation on key secondary endpoints,including CGI-S and the PANSS Marder positive factor.-- ML-007C-MA was generally well tolerated, with no serious or drug-related. severe adverse events and low rates of GI-related discontinuations. Its. clinical profile, including simple initiation, 99% of patients reaching","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0942090050.USD","LU0061474705.USD","LU2168564222.USD","UYG","LU0965509010.AUD","LU2347655073.USD","BK4585","IPAY","BK4613","LU0672654240.SGD","LU0006306889.USD","ADP","LU2764262908.HKD","LU2023250504.SGD","LU1989764748.USD","LU2417539215.USD","IE00BYQQ9H92.USD","LU0174119429.USD","LU1718418525.SGD","LU1084165304.USD","LU2360107671.USD","LU1623119135.USD","STBQ","LU2404859667.USD","XLF","LU2462157665.USD","IE00B1XK9C88.USD","LU0353189763.USD","LATR","LU1145028129.USD","LU0056508442.USD","MA","IYG","LU0868494617.USD","LU1236620750.USD","IE0005OL40V9.USD","LU1316542783.SGD","VFH","ASD","IE00BQXX3C00.GBP","IE000F7OJYX1.SGD","IE000WAW04H5.SGD","LU0234570918.USD","MPLT","LU2361044865.SGD","BK4559","IE00B775H168.HKD","FNCL","FDFF","IE00BJJMRX11.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157908","title":"MapLight Therapeutics Prices USD 150 Million PIPE at USD 11.38 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157908","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157908?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626622,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics prices USD 150 million PIPE at USD 11.38 a shareMapLight Therapeutics priced a USD 150 million PIPE of unregistered equity securities, led by new and existing institutional inves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3K2fQX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","IE00BKPKM429.USD","MPLT","SG9999014039.USD","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","SG9999014013.SGD","NDAQ","BCDF","IE00BN0W2T93.GBP","BK4112","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659979157","title":"Maplight Therapeutics Announces $150 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659979157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659979157?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2BY2WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157434","title":"MapLight Therapeutics Announces $150 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157434","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157434?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:10","pubTimestamp":1786626600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and BOSTON, Aug.  13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344584/0/en/maplight-therapeutics-announces-150-million-private-placement-financing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956143","title":"MapLight Therapeutics Price Target Cut to $13.00/Share from $52.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956143","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956143?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:00","pubTimestamp":1786392000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MPLT/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658793933","title":"UBS Downgrades MapLight Therapeutics to Neutral From Buy, Adjusts PT to $13 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2658793933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658793933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:43","pubTimestamp":1786362188,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics (MPLT) has an average rating of Buy and mean price target of $32.31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657195595","title":"Maplight Therapeutics CSO Lillie James Woodruff Sells 22,082 Shares for $276,908.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2657195595","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657195595?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:40","pubTimestamp":1785890431,"startTime":"0","endTime":"0","summary":"Maplight Therapeutics CSO Lillie James Woodruff sells 22,082 shares for $276,908.28Maplight Therapeutics Chief Scientific Officer Lillie James Woodruff sold 22,082 shares of voting common stock on Aug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL2JY0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maplight Therapeutics CSO Lillie James Woodruff Sells 22,082 Shares for $276,908.28","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655384282","title":"Catalyst4 Reports $13.84 Million MapLight Therapeutics Common Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2655384282","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655384282?lang=en_us&edition=fundamental","pubTime":"2026-07-31 06:40","pubTimestamp":1785451206,"startTime":"0","endTime":"0","summary":"Catalyst4 reports $13.84 million MapLight Therapeutics common share purchaseCatalyst4, a 10% owner of Maplight Therapeutics, reported open-market purchases totaling 1,209,225 voting common shares.Purc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLfqNPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Catalyst4 Reports $13.84 Million MapLight Therapeutics Common Share Purchase","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655801359","title":"MapLight Therapeutics, Inc. (MPLT) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2655801359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655801359?lang=en_us&edition=fundamental","pubTime":"2026-07-30 23:26","pubTimestamp":1785425177,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Buy rating on MapLight Therapeutics, Inc. today and set a price target of $25.00. In addition to Jefferies, MapLight...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maplight-therapeutics-inc-mplt-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maplight-therapeutics-inc-mplt-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655342048","title":"Maplight Therapeutics Director Troy Cox Reports Purchase of 15,620 Shares Worth $148,702.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2655342048","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655342048?lang=en_us&edition=fundamental","pubTime":"2026-07-29 09:15","pubTimestamp":1785287721,"startTime":"0","endTime":"0","summary":"Maplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4Maplight Therapeutics director Troy Cox reported buying 15,620 shares of voting common stock at a weighted ave","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDLb1bBRH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maplight Therapeutics Director Troy Cox Reports Purchase of 15,620 Shares Worth $148,702.4","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654500961","title":"MapLight Therapeutics price target lowered to $24 from $43 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2654500961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654500961?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:20","pubTimestamp":1785237629,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on MapLight Therapeutics (MPLT) to $24 from $43 and keeps a Buy rating on the shares. The firm updated it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-24-from-43-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-24-from-43-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006677","title":"MapLight downgraded to Equal Weight from Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006677?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:56","pubTimestamp":1785236218,"startTime":"0","endTime":"0","summary":"Morgan Stanley downgraded MapLight Therapeutics (MPLT) to Equal Weight from Overweight with a price target of $21, down from $34. While the ZEPHYR ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654058910","title":"MapLight Therapeutics is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2654058910","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654058910?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:28","pubTimestamp":1785234480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MPLT/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071164","title":"U.S. Research Roundup- BioLife Solutions, Gossamer Bio, Intuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071164","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071164?lang=en_us&edition=fundamental","pubTime":"2026-07-28 15:31","pubTimestamp":1785223918,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, IntuitJuly 28 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BioL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL4N43U0K0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUT","CBOE","BLFS","SRCE","CDNS","NVTS","CLSK","LW","AGYS","BKR","OWL","GSHD","PPA","HIG","STCE","GDX","GTY","HBT","NEM","IDU","CIFR","FFIV","LMTS","NEE","RNWZ","CHRW","HAPN","MPLT","INTU","FRPT","IP","BY","DIPR","ENSG","WDGF","FMBH","HCA","CHMG","OTIS","HTH","GOSS","HRB","MSBI","BRBR","CUT","LMTL","LMT","BWFG","PINE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maplightrx.com","stockEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.7001},{"period":"3month","weight":-0.6094},{"period":"6month","weight":-0.3719},{"period":"1year","weight":-0.3394},{"period":"ytd","weight":-0.3607}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"MapLight Therapeutics, Inc.","nameEN":"MapLight Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MapLight Therapeutics, Inc.(MPLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MapLight Therapeutics, Inc.,MPLT,MapLight Therapeutics, Inc.股票,MapLight Therapeutics, Inc.股票老虎,MapLight Therapeutics, Inc.股票老虎国际,MapLight Therapeutics, Inc.行情,MapLight Therapeutics, Inc.股票行情,MapLight Therapeutics, Inc.股价,MapLight Therapeutics, Inc.股市,MapLight Therapeutics, Inc.股票价格,MapLight Therapeutics, Inc.股票交易,MapLight Therapeutics, Inc.股票购买,MapLight Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MapLight Therapeutics, Inc.(MPLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}